• $7.5B
    Market Cap
  • 56.72%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-794.3M
+66.65%
-476.6M
+43.42%
-332.3M
+96.13%
-169.5M
+116.11%
Depreciation and Amortization Expense
16.4M
+134.13%
7.0M
+121.89%
3.2M
+22.47%
2.6M
+43.17%
Total Operating Expenses
923.7M
+62.18%
569.5M
+21.69%
468.0M
+101.52%
232.3M
+124.03%
Operating Profit
-923.7M
+62.18%
-569.5M
+21.69%
-468.0M
+101.52%
-232.3M
+124.03%
Interest Income
119.7M
+8.84%
110.0M
+74.85%
62.9M
+652.84%
8.4M
+2,329.07%
Interest Expense
N/A
N/A
N/A
N/A
0
+100.00%
-2,000
-71.43%
Interest Income and Expense and Net
119.7M
+8.84%
110.0M
+74.85%
62.9M
+653.02%
8.4M
+2,378.93%
Total Nonoperating Income and Expense
157.0M
+48.69%
105.6M
+60.58%
65.8M
+649.91%
8.8M
+144.11%
Income before Taxes
-923.7M
+62.18%
-569.5M
+21.69%
-468.0M
+101.52%
-232.3M
+124.03%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
0
N/A
0
-100.00%
213,000
N/A
Net Income
-766.6M
+65.25%
-463.9M
+15.33%
-402.3M
+80.00%
-223.5M
+123.31%
Net Income from Continuing Operations Applicable to Common
-766.6M
+65.25%
-463.9M
+15.33%
-402.3M
+80.00%
-223.5M
+123.31%
Basic EPS and Net Income
-5.63
+48.16%
-3.80
-8.21%
-4.14
+20.35%
-3.44
+78.24%
Diluted EPS and Net Income
-5.63
+48.16%
-3.80
-8.21%
-4.14
+20.35%
-3.44
+78.24%
Basic Weighted Average Shares
136.1M
+11.55%
122.0M
+25.57%
97.2M
+49.75%
64.9M
+24.95%
Diluted Weighted Average Shares
136.1M
+11.55%
122.0M
+25.57%
97.2M
+49.75%
64.9M
+24.95%
Balance Sheet
Cash and Cash Equivalents
174.0M
-55.15%
387.9M
-2.41%
397.5M
-52.38%
834.7M
+1,109.91%
Short-Term Investments
1.4B
+2.04%
1.4B
+99.09%
682.8M
+605.94%
96.7M
-45.35%
Cash and Cash Equivalents and Short-Term Investments
1.6B
-10.66%
1.7B
+61.74%
1.1B
+15.98%
931.4M
+278.65%
Total Current Assets
1.6B
-8.98%
1.8B
+63.14%
1.1B
+16.27%
942.6M
+267.69%
Accumulated Depreciation
32.8M
+101.36%
16.3M
+75.52%
9.3M
+51.58%
6.1M
+72.41%
Property and Plant and Equipment and Net
257.4M
+29.96%
198.0M
+148.72%
79.6M
+668.59%
10.4M
+30.25%
Total Long-Term Assets
1.4B
-20.19%
1.7B
+452.42%
312.0M
+390.33%
63.6M
-6.42%
Total Assets
3.0B
-14.48%
3.5B
+149.40%
1.4B
+39.93%
1.0B
+210.23%
Income Taxes Payable
4.7M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
205.8M
+46.78%
140.2M
-3.55%
145.3M
+258.64%
40.5M
+41.12%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
100,000
0.00%
100,000
N/A
0
-100.00%
9,000
-90.62%
Total Liabilities
317.2M
+54.36%
205.5M
+22.72%
167.4M
+218.56%
52.6M
+30.37%
Retained Earnings
-2.2B
+55.22%
-1.4B
+50.19%
-924.4M
+77.04%
-522.1M
+74.83%
Total Stockholders Equity
2.7B
-18.76%
3.3B
+166.50%
1.2B
+30.08%
953.6M
+235.76%
Total Shares Outstanding
131.1M
+4.94%
124.9M
+30.96%
95.4M
+20.00%
79.5M
+49.85%
Cash Flow
Cash from Operating Activities
-655.6M
+44.84%
-452.6M
+52.51%
-296.8M
+73.97%
-170.6M
+40.53%
Capital Expenditures
13.7M
-38.85%
22.4M
+39.63%
16.1M
+174.66%
5.8M
-10.79%
Cash from Investing Activities
437.4M
+121.81%
-2.0B
+159.36%
-773.3M
-1,136.82%
74.6M
+135.13%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.0M
-99.92%
2.4B
+282.69%
639.8M
-25.74%
861.5M
+4,741.24%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-23.54%
+24.79%
-18.86%
-43.40%
-33.33%
-0.80%
-33.59%
+20.37%
Return on Equity
-25.59%
+25.39%
-20.41%
-44.34%
-36.67%
+1.53%
-36.11%
+13.65%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
7.91
-37.99%
12.75
+69.15%
7.54
-67.58%
23.26
+160.54%
Cash Ratio
0.85
-69.44%
2.77
+1.18%
2.73
-86.72%
20.60
+757.35%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow